Phase III Comparison of Standard Doxorubicin and Cyclophosphamide Versus Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor As Neoadjuvant Therapy for Inflammatory and Locally Advanced Breast Cancer: SWOG 0012

PURPOSE: Patients with inflammatory breast cancer (IBC) or locally advanced breast cancer (LABC) were randomly assigned to 21-day doxorubicin and cyclophosphamide administered for five cycles (standard arm) versus weekly doxorubicin and daily oral cyclophosphamide administered with granulocyte colon...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ellis, Georgiana K., Barlow, William E., Gralow, Julie R., Hortobagyi, Gabriel N., Russell, Christy A., Royce, Melanie E., Perez, Edith A., Lew, Danika, Livingston, Robert B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2011
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068051/
https://ncbi.nlm.nih.gov/pubmed/21220618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.6543
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak